Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer - Concepedia

Concepedia

Publication | Closed Access

Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer

46

Citations

47

References

2023

Year

Yi Zhang, Silvia K. Tacheva-Grigorova, Janette Sutton, Zea Melton, Yvonne S.L. Mak, Cecilia Lay, B. Smith, Tao Sai, Thomas Van Blarcom, Barbra J. Sasu,

Clinical Cancer Research

Abstract

In summary, the preclinical efficacy and safety data presented here support further evaluation of DLL3 CAR T cells as potential clinical candidates for the treatment of SCLC.

References

	Year	Citations

Page 1